A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation

Clinical trial NCT00672152 · TERMINATED

Trial details

NCT number: NCT00672152
Sponsor: Michael Morse, MD
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia (AML)Chronic Myelogenous Leukemia (CML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndrome (MDS)B Cell Malignancies

Start date: 2007-06-01
Primary completion: 2013-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.